All In Biotech

Drug Trial Radar · NCT03150693

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 303 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

303

Planned (sponsor's estimate)

Start

Sep 20, 2017

Primary completion

Nov 1, 2027

Study completion Apr 1, 2028

Sponsor

Lead sponsor
Alliance for Clinical Trials in OncologyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Cancer Institute (NCI)
First posted
May 12, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 39 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in treating patients with newly diagnosed B acute lymphoblastic leukemia. Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a chemotherapy drug called ozogamicin. Inotuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as CD22 receptors, and delivers ozogamicin to kill them. Chemotherapy drugs, such as \[intervention\], work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia.

Conditions

  • B Acute Lymphoblastic Leukemia

Interventions

  • AllopurinolDrug

    Given PO

  • CytarabineDrug

    Given IT, IV, SC

  • Daunorubicin HydrochlorideDrug

    Given IV

  • Vincristine SulfateDrug

    Given IV

  • DexamethasoneDrug

    Given PO or IV

  • Pegylated L-AsparaginaseDrug

    Given IV

  • MethotrexateDrug

    Given IT, IV, PO

  • Bone Marrow Aspiration and BiopsyProcedure

    Undergo bone marrow aspiration and biopsy

  • CyclophosphamideDrug

    Given IV

  • MercaptopurineDrug

    Given PO

  • RituximabBiological

    Given IV

  • DoxorubicinDrug

    Given IV

  • ThioguanineDrug

    Given PO

  • Inotuzumab OzogamicinBiological

    Given IV

  • Laboratory Biomarker AnalysisOther

    Correlative studies

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Event-free survival (EFS)Time frame: Time from induction response to the time of progressive-disease, secondary malignancy, or death, assessed up to 3 years

Locations

460 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama · Active not recruiting

  • Anchorage Associates in Radiation Medicine

    Anchorage, Alaska · Suspended

  • Anchorage Radiation Therapy Center

    Anchorage, Alaska · Suspended

  • Alaska Breast Care and Surgery LLC

    Anchorage, Alaska · Suspended

  • Alaska Oncology and Hematology LLC

    Anchorage, Alaska · Suspended

  • Alaska Women's Cancer Care

    Anchorage, Alaska · Suspended

  • Anchorage Oncology Centre

    Anchorage, Alaska · Suspended

  • Katmai Oncology Group

    Anchorage, Alaska · Suspended

  • Providence Alaska Medical Center

    Anchorage, Alaska · Suspended

  • Fairbanks Memorial Hospital

    Fairbanks, Alaska · Suspended

  • Kingman Regional Medical Center

    Kingman, Arizona · Suspended

  • Mayo Clinic Hospital in Arizona

    Phoenix, Arizona · Suspended

  • Mayo Clinic in Arizona

    Scottsdale, Arizona · Withdrawn

  • Mercy Hospital Fort Smith

    Fort Smith, Arkansas · Suspended

  • Kaiser Permanente-Deer Valley Medical Center

    Antioch, California · Recruiting

  • PCR Oncology

    Arroyo Grande, California · Suspended

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center

    Burbank, California · Suspended

  • Community Cancer Institute

    Clovis, California · Recruiting

  • University Oncology Associates

    Clovis, California · Suspended

  • UC Irvine Health Cancer Center-Newport

    Costa Mesa, California · Recruiting

  • Kaiser Permanente Dublin

    Dublin, California · Recruiting

  • Kaiser Permanente-Fremont

    Fremont, California · Recruiting

  • Fresno Cancer Center

    Fresno, California · Suspended

  • Kaiser Permanente Fresno Orchard Plaza

    Fresno, California · Recruiting

  • Kaiser Permanente-Fresno

    Fresno, California · Recruiting

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

    Irvine, California · Recruiting

  • Kaiser Permanente- Modesto MOB II

    Modesto, California · Recruiting

  • Kaiser Permanente-Modesto

    Modesto, California · Recruiting

  • Kaiser Permanente Oakland-Broadway

    Oakland, California · Suspended

  • Kaiser Permanente-Oakland

    Oakland, California · Recruiting

  • UC Irvine Health/Chao Family Comprehensive Cancer Center

    Orange, California · Recruiting

  • Stanford Cancer Institute Palo Alto

    Palo Alto, California · Recruiting

  • Kaiser Permanente-Rancho Cordova Cancer Center

    Rancho Cordova, California · Suspended

  • Kaiser Permanente- Marshall Medical Offices

    Redwood City, California · Suspended

  • Kaiser Permanente-Redwood City

    Redwood City, California · Suspended

  • Kaiser Permanente-Richmond

    Richmond, California · Recruiting

  • Rohnert Park Cancer Center

    Rohnert Park, California · Suspended

  • Kaiser Permanente-Roseville

    Roseville, California · Recruiting

  • The Permanente Medical Group-Roseville Radiation Oncology

    Roseville, California · Suspended

  • Kaiser Permanente Downtown Commons

    Sacramento, California · Recruiting

Showing 40 of 460 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.